Primary SCC of the ovary typically arises from malignant transformation within a mature cystic teratoma and is characterized by molecular alterations such as TP53 and EGFR mutations, with no significant association with HPV, unlike SCCs in other anatomical locations [17]. The gene discussed is TP53; the disease is cystic teratoma.